Dennis Wiedijk
About Dennis Wiedijk
Dennis Wiedijk is a Cell Therapy Specialist II+ and Process Lead at Kite Pharma, where he has worked since 2019, focusing on advancing oncology therapies. He has a diverse background in pharmaceutical operations, having held various roles in companies such as Wacker Biotech and Teva Pharmachemie.
Work at Kite Pharma
Dennis Wiedijk has been employed at Kite Pharma since 2019, serving as a Cell Therapy Specialist II+ and Process Lead. In this role, he works in Hoofddorp, focusing on advancing oncology therapies, particularly in cell therapy, immuno-oncology, and targeted therapy. He is part of a team dedicated to transformational drug development aimed at curing cancer. His contributions involve the development of genetically engineered immune cells for cancer treatment.
Previous Experience in Biotech
Before joining Kite Pharma, Dennis Wiedijk held several positions in the biotech industry. He worked at Wacker Biotech Amsterdam as an Allround Operator in filling and finishing from 2016 to 2018 and as a Process Operator in USP from 2014 to 2016. Additionally, he was employed at SynCo Bio Partners B.V. as a Process Operator USP from 2011 to 2013. His experience in these roles provided him with a solid foundation in biopharmaceutical manufacturing processes.
Education and Expertise
Dennis Wiedijk studied at ROC Leiden, where he completed a program in Allround Laborant BBL 3 from 2009 to 2011. He also attended Edufarma, where he studied Good Manufacturing Practices (GMP) and achieved the certification of Farmaceutisch Vakman in 2014. His educational background equips him with the necessary skills and knowledge to excel in the field of cell therapy and biopharmaceuticals.
Career Development
Dennis Wiedijk's career in the pharmaceutical industry began at Teva Pharmachemie, where he worked as a Farmacheutisch medewerker Parenterals from 2013 to 2014. He also gained early experience as a Laborant in opleiding at Crown Van Gelder B.V. from 2008 to 2011. Over the years, he has developed a diverse skill set in various roles, contributing to his expertise in cell therapy and drug development.